Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.
Roques P, Ljungberg K, Kümmerer BM, Gosse L, Dereuddre-Bosquet N, Tchitchek N, Hallengärd D, García-Arriaza J, Meinke A, Esteban M, Merits A, Le Grand R, Liljeström P. Roques P, et al. JCI Insight. 2017 Mar 23;2(6):e83527. doi: 10.1172/jci.insight.83527. JCI Insight. 2017. PMID: 28352649 Free PMC article.
Morbidity due to this virus is a serious threat to public health, but at present, there is no vaccine against this debilitating disease. We have recently developed a number of vaccine candidates, and here we have evaluated 3 of them in a nonhuman
Morbidity due to this virus is a serious threat to public health, but at present, there is no vaccine against this debilitatin …
Vaccines in development against West Nile virus.
Brandler S, Tangy F. Brandler S, et al. Viruses. 2013 Sep 30;5(10):2384-409. doi: 10.3390/v5102384. Viruses. 2013. PMID: 24084235 Free PMC article. Review.
In this review, we discuss the state-of-the-art of West Nile vaccine development and the potential of a novel safe and effective approach based on recombinant live attenuated measles virus (MV) vaccine. MV vaccine is a live attenuated neg …
In this review, we discuss the state-of-the-art of West Nile vaccine development and the potential of a novel safe and effective appr …